scholarly journals Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart Failure

Circulation ◽  
1999 ◽  
Vol 99 (25) ◽  
pp. 3224-3226 ◽  
Author(s):  
Anita Deswal ◽  
Biykem Bozkurt ◽  
Yukihiro Seta ◽  
Semahat Parilti-Eiswirth ◽  
F. Ann Hayes ◽  
...  
2002 ◽  
Vol 236 (2) ◽  
pp. 254-260 ◽  
Author(s):  
Vishnu K. Rumalla ◽  
Steve E. Calvano ◽  
Alan J. Spotnitz ◽  
Tyrone J. Krause ◽  
Robert J. Hilkert ◽  
...  

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Liana Xhakollari ◽  
Amra Jujic ◽  
John Molvin ◽  
Peter M Nilsson ◽  
Hannes Holm ◽  
...  

Abstract Background and Aims The “Shrunken pore syndrome” is characterized by a difference in renal filtration between cystatin C and creatinine resulting in a low eGFRcystatinC/eGFRcreatinine-ratio, and studies have demonstrated a high risk for cardiovascular morbidity and mortality for patients with shrunken pore syndrome. In this observational study, we explored associations between shrunken pore syndrome and proteins implicated in cardiovascular disease and inflammation in patients with heart failure. Method Plasma samples from 300 individuals HARVEST-Malmö trial hospitalized for the diagnosis of heart failure (mean age 75 years; 30% female), were analyzed with a proximity extension assay consisting of 92 proteins, to identify proteins associated with shrunken pore syndrome. Shrunken pore syndrome was defined as eGFRcystatinC ≤60% of eGFRcreatinine. Proteins associated with shrunken pore syndrome in the initial age and sex-adjusted analyses (Bonferroni-corrected p≤ 5.4x10-4) were further adjusted for relevant covariates. Results In multivariate analyses, Shrunken pore syndrome was associated with elevated levels of six proteins; scavenger receptor cysteine-rich type 1 protein M130, tumor necrosis factor receptor 1, tumor necrosis factor receptor 2, osteoprotegerin, interleukin-2 receptor subunit alpha, and tyrosine-protein kinase receptor UFO (p<0.05). Conclusion In heart failure patients, shrunken pore syndrome was independently associated with proteins linked to atherosclerosis and cell proliferation.


Circulation ◽  
2009 ◽  
Vol 119 (10) ◽  
pp. 1386-1397 ◽  
Author(s):  
Tariq Hamid ◽  
Yan Gu ◽  
Roger V. Ortines ◽  
Chhandashri Bhattacharya ◽  
Guangwu Wang ◽  
...  

2002 ◽  
Vol 320 (1-2) ◽  
pp. 65-67 ◽  
Author(s):  
Antti Saraste ◽  
Liisa-Maria Voipio-Pulkki ◽  
Päivi Heikkilä ◽  
Petri Laine ◽  
Markku S Nieminen ◽  
...  

Circulation ◽  
2001 ◽  
Vol 103 (8) ◽  
pp. 1044-1047 ◽  
Author(s):  
Biykem Bozkurt ◽  
Guillermo Torre-Amione ◽  
Marshelle Smith Warren ◽  
James Whitmore ◽  
Ozlem Z. Soran ◽  
...  

2005 ◽  
Vol 1 (3) ◽  
pp. 119-124
Author(s):  
Simone de Lima e Sil Deo ◽  
Maria do Carmo Valen Crasto ◽  
Alda Maria Da-Cruz ◽  
Milton Ozório Moraes ◽  
Alexandre Pio Abreu ◽  
...  

2007 ◽  
Vol 13 (6) ◽  
pp. S101-S102
Author(s):  
Akash Makkar ◽  
Javier Banchs ◽  
Mary A. Hauck ◽  
Tariq S. Siddiqui ◽  
Saeed A. Jortani ◽  
...  

2011 ◽  
Vol 3 (1) ◽  
pp. 64
Author(s):  
Mona Yolanda ◽  
Marsetio Donosepoetro ◽  
Anwar Santoso ◽  
Mansyur Arif

BACKGROUND: Heart failure (HF) is associated with an increased expression of proinflammatory cytokines, especially soluble tumor necrosis factor receptor I (sTNFR I), but the underlying mechanism to the relationship between sTNFR I activation and the progression of HF is not yet fully understood. This study aims to see the association between sTNFR I, MMP-9, PICP, and NT-proBNP in the progression of HF.METHODS: This was a cross sectional study which recruited 45 subjects with HF confirmed by echocardiography and NT-proBNP. Concentration sTNFR I, MMP-9, and PICP were measured using ELISA method, whereas NT-proBNP concentration was measured using ECLIA method. Univariate linear regression analysis, path analysis and General Linear Model were used to determine which parameters played the most significant role in HF.RESULTS: Results of the univariate linear regression and path analysis showed there was a linear relationship between sTNFR I with MMP-9, with R square of 25.8% (p=0.00; r=0.508), R square sTNFRI and MMP-9 with PICP was 14.4% (p=0.038; r=0.379) and R square MMP-9 and PICP with NT-proBNP was 39.6% (p=0.00; r=0.629). From the General Linear Model we found that the important predictor for HF was through MMP-9 and PICP.CONCLUSION: sTNFR I as a proinflammatory factor is one of the factors involved in the heart failure as seen by NT-proBNP through activation of brosis (PICP) and remodeling factor (MMP-9).KEYWORDS: sTNFR I, MMP-9, PICP, NT-proBNP, heart failure


Circulation ◽  
2001 ◽  
Vol 104 (25) ◽  
pp. 3023-3025 ◽  
Author(s):  
Stephan Fichtlscherer ◽  
Lothar Rössig ◽  
Susanne Breuer ◽  
Mariuca Vasa ◽  
Stefanie Dimmeler ◽  
...  

1996 ◽  
Vol 27 (2) ◽  
pp. 70-71 ◽  
Author(s):  
Richard V. Milani ◽  
Stefan Endres ◽  
Mandeep R. Mehra ◽  
Julia Cook ◽  
Andreas Eigler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document